The Scientist

» rare diseases and neuroscience

Most Recent

image: Shire Buys Rare Disease Drug Developer

Shire Buys Rare Disease Drug Developer

By | November 2, 2015

The Irish drugmaker is set to acquire the Massachusetts-based Dyax in a $5.9 billion deal.

0 Comments

image: Appetite, Obesity, and the Brain

Appetite, Obesity, and the Brain

By | November 1, 2015

How the foods that make us fattest are not that different from heroin and cocaine

0 Comments

image: Embracing the Unknown

Embracing the Unknown

By | November 1, 2015

Researchers are showing that ambiguity can be essential to brain development.

1 Comment

image: Heady Stuff

Heady Stuff

By | November 1, 2015

New research on how fat influences brain neuronal activity

1 Comment

image: Remote Mind Control

Remote Mind Control

By | November 1, 2015

Using chemogenetic tools to spur the brain into action

0 Comments

image: Rewarding Companions

Rewarding Companions

By | October 26, 2015

Oxytocin and social contact together modulate endocannabinoid activity in the mouse brain, which could help explain the prosocial effects of marijuana use. 

0 Comments

image: Electrode-Free Electrophysiology

Electrode-Free Electrophysiology

By | October 22, 2015

Optogenetics has evolved beyond its neuron-stimulating capacities to an all-optical approach for both manipulating and recording cells.

0 Comments

image: Speaking of Neuroscience

Speaking of Neuroscience

By | October 22, 2015

A selection of notable quotes from the Society for Neuroscience meeting

0 Comments

image: New Hope for Alzheimer’s Blood Test

New Hope for Alzheimer’s Blood Test

By | October 19, 2015

Using autoantibodies as biomarkers, researchers could soon identify people at the highest risk of developing neurodegenerative diseases much earlier than existing methods.

0 Comments

image: Cognitive Neuroscience Lurking in Art

Cognitive Neuroscience Lurking in Art

By | October 19, 2015

What can neuroscientists learn from the masters and other artists?

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech